"PEGyAMPH: A Novel Anti-Obesity Agent"
- 🧠 Brain-sparing treatment alters sympathetic activity
- 🧊 Increases NE, lipolysis, and thermogenesis
- 🩺 No cardiovascular side effects observed
- 🐁 Maintains normothermia through tail vasodilation

#ObesityResearch #DrugDevelopment https://tnyp.me/kzRoO838/m

PEGylated Amphetamine as an Anti-Obesity Drug

🎯 Does not cross BBB, reducing side effects
🍽️ Maintained normothermia, unlike AMPH
📉 Better insulin sensitivity observed
🩺 Blood pressure unaffected with peripheral use

#ObesityResearch #Pharmacology https://dev.tnyp.me/gWcQeLtR/m

Scientists built a whole-body obesity map using AI and honestly it slaps

https://worldbriefly.news/scientists-built-a-whole-body-obesity-map-using-ai-and-honestly-it-slaps

#ObesityResearch #AIHealthcare #MedicalScience

BRAINSPAR-eDT unveils a novel anti-obesity compound, PEGyAMPH.

- 🧪 Reduces weight gain without affecting food intake.
- ⚙️ Enhances lipolysis and thermogenesis.
- 🫀 No cardiovascular side effects noted.
- 📈 Improves insulin sensitivity, distinct from AMPH.

#CellMetab #ObesityResearch #BRAINSPAR https://tnyp.me/kzRoO838/m

Novel Amphetamine Derivative for Obesity

🔬PEGyAMPH selectively targets sympathetic pathways.

#ObesityResearch #Pharmacology #MetabolicHealth https://tnyp.me/kzRoO838/m

A new daily pill, orforglipron, has been found to help people maintain weight loss after stopping GLP-1 injections, with participants keeping over 70% of their earlier weight loss off 📊💊. The study's results are promising, but more research is needed to determine the long-term effects of this medication.

#DiscoverHeadlines #WeightLossTreatment #ObesityResearch...

(Read More)
https://www.discoverheadlines.com/2026/05/new-daily-pill-could-help-maintain.html

Discover how incretin-based therapies like GLP-1 RAs combat obesity-related heart and kidney complications through weight loss and direct organ protection.
https://mondaldaffodil.wixsite.com/besthealthcaretips/post/how-incretins-combat-obesity-related-cardiovascular-and-renal-risks

#ObesityResearch #CardiovascularHealth #RenalHealth #GLP1 #MedicalScience #ChronicKidneyDisease #HeartHealth

🧬 Mother's obesity rewires baby's liver cells before birth!

New study shows how maternal weight affects children's health—even with healthy diets.

60% of offspring develop fatty liver disease due to cellular "reprogramming."

Weight loss before pregnancy reduces risks.

https://karmactive.com/maternal-obesity-reprograms-fetal-liver-cells-60-of-offspring-develop-fatty-liver-despite-healthy-diets/

#MaternalHealth #ObesityResearch

Follow @karmactive for more updates.

New study shows how a whiff of food can trick your brain into feeling full—unless you're obese. #Neuroscience #SmellAndSatiety #ObesityResearch

https://geekoo.news/how-smelling-food-can-shut-down-hunger-in-the-brain/